Sweet Financial Partners »

Immunic shares owned by Sweet Financial Partners

Quarter-by-quarter ownership of Immunic (IMUX) shares owned by Sweet Financial Partners from 13F filings

Historical chart of Sweet Financial Partners investment in Immunic

Tip: Access up to 7 years of quarterly data

All positions including Immunic held by Sweet Financial Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Immunic by Sweet Financial Partners

Quarter filed Position value Share count Share price at filing
2024-03-31 $39k 30k 1.32
2023-12-31 $45k 30k 1.50

More positions owned by Sweet Financial Partners

Vanguard Index Fds S&p 500 Etf Shs (VOO)
Schwab Strategic Tr Us Dividend Eq (SCHD)
First Tr Exchange-traded Risng Divd Achiv (RDVY)
Vanguard Intl Equity Index F Vanguard Intl Equity Index F (VEU)
Ishares Tr Exponential Tech (XT)
First Tr Exch Traded Fd Iii Lng/sht Equity (FTLS)
First Tr Exchange-traded Fst Low Oppt Eft (LMBS)
First Tr Exchange-traded Growth Strength (FTGS)
First Tr Exchange Traded Nasdaq Cyb Etf (CIBR)
Wisdomtree Tr Em Ex St-owned (XSOE)
Spdr Ser Tr Portfolio Short (SPSB)
Apple (AAPL)
Spdr Index Shs Fds S&p North Amer (NANR)
Microsoft Corporation (MSFT)
Visa Com Cl A (V)

View all positions for Sweet Financial Partners

Top funds holding Immunic

Vanguard Group
Gratus Capital
Omega Fund Management
BlackRock
Ikarian Capital
Logos Global Management
Soleus Capital Management
Susquehanna International
Acadian Asset Management
Two Sigma Advisers
Schonfeld Strategic Advisors
Two Sigma Investments
Bank of America Corporation
Citadel Advisors
Connor, Clark & Lunn Investment Management

View all funds holding Immunic